Press Release Rimegepant is Now Available in the Philippines for Both the Acute Treatment of Migraine and the Preventive Treatment of Episodic MigraineBy Lion's DenDecember 13, 2023 Pfizer Philippines today announces the availability of Rimegepant, a calcitonin gene-related peptide (CGRP) receptor antagonist for both the acute treatment…
Press Release Pfizer Philippines, PCOM elevate healthcare professionals’ capabilities in landmark partnership to optimize health of Filipino workforceBy Lion's DenNovember 8, 2023 Pfizer Philippines has partnered with the PCOM in an aim to provide educational initiatives to HCPs, promote enhanced learning, and…
